Abstract:A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r2, q2, and r2test values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC50 values of 9.124 and docking scoring values of −14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to design new inhibitors of the PLpro enzyme of the SARS - CoV - 2 virus. Specifically, the researchers used quantitative structure - activity relationship (QSAR), molecular docking and molecular dynamics simulation methods to design a series of new benzothiophene and benzimidazole derivatives. These compounds can bind to the C111, Y268 and H73 sites of the PLpro enzyme, thereby inhibiting the activity of this enzyme. The main goal of the study was to discover potential drug candidates with high affinity and good antiviral activity to combat SARS - CoV - 2 virus infection. ### Research Background The non - structural protein PLpro of the SARS - CoV - 2 virus participates in post - translational modification in cells and helps the virus evade the host's antiviral immune response mechanism. Therefore, the development of effective PLpro inhibitors is considered one of the important strategies for the treatment of SARS - CoV - 2 infection. ### Research Methods 1. **QSAR Analysis**: The researchers constructed a combined QSAR equation containing physicochemical properties and Free - Wilson descriptors to predict the antiviral activity of compounds. Through cross - validation, a five - component partial least squares (PLS) model was obtained, and its internal and external validation parameters all showed good statistical performance. 2. **Molecular Docking**: Molecular docking technology was used to evaluate the binding mode and affinity of the newly designed compounds with the PLpro enzyme. 3. **Molecular Dynamics Simulation**: Molecular dynamics simulation was further used to verify the stability and interaction of the compounds at the binding sites of the PLpro enzyme. ### Main Results - **QSAR Model**: The final QSAR equation is: \[ \text{pIC}_{50} = 3.84264 - 0.23411nF - 0.79971nCl - 0.21961nO + 0.16803\text{ALogP} + 0.04589\text{ALogP}^2 + 0.00796\text{AMR} + 0.00119\text{DPSA - 3} + 0.2659n\text{Ar} + 0.17442n\text{Basic} + 0.22252n\text{Acid} + 0.07801n\text{HBDon} + 0.00225\text{TopoPSA} + 0.00145\text{VABC} \] where the meanings of each descriptor are as follows: - ALogP: Hydrophobicity - ALogP2: Square of ALogP - AMR: Molar refractivity - DPSA - 3: Difference between PPSA - 3 and PNSA - 3 - nAr: Number of aromatic rings - nBasic: Number of basic nitrogen atoms - nAcid: Number of carboxylic acid groups - nF: Number of fluorine atoms - nCl: Number of chlorine atoms - nHBDon: Number of hydrogen - bond - donor atoms - nO: Number of oxygen atoms - TopoPSA: Topological polar surface area - VABC: Van der Waals volume considering atomic and bond contributions - **Molecular Docking and Dynamics Simulation**: The binding affinities of the best compounds Pred14 and Pred15 at the C111, Y268 and H73 sites were pIC50 values of 9.124 and docking score values of - 14 kcal/mol, respectively. Molecular dynamics simulation showed that these compounds had high stability and good interactions in the binding pocket. ### Conclusion Through QSAR, molecular docking and molecular dynamics simulation, the researchers successfully designed a series of new benzothiophene and benzimidazole derivatives. These compounds have high affinity and good antiviral activity for the PLpro enzyme of the SARS - CoV - 2 virus. In particular, Pred14 and Pred15 were identified as potential antiviral drug candidates and are worthy of further experimental verification.

Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme

Computational Discovery of Novel Imidazole Derivatives as Inhibitors of SARS-CoV-2 Main Protease: An Integrated Approach Combining Molecular Dynamics and Binding Affinity Analysis

Novel Alkynylamide-Based Nonpeptidic Allosteric Inhibitors for SARS-CoV-2 3-Chymotrypsin-like Protease

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease

Insight into crystal structures and identification of potential styrylthieno[2,3-b]pyridine-2-carboxamidederivatives against COVID-19 Mpro through structure-guided modeling and simulation approach

Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2

In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening

Pharmacotherapeutic Potential of Natural Products to Target the SARS-CoV-2 PLpro Using Molecular Screening and Simulation Approaches

Receptor-Based Pharmacophore Modelling of a series of ligands used as inhibitors of the SARS-CoV-2 virus by complementary theoretical approaches, molecular docking, and reactivity descriptors.

Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation

Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2

Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking

DFT, Molecular Docking, ADME, and Cardiotoxicity studies of Persuasive Thiazoles as Potential Inhibitors of the Main Protease of SARS‐CoV‐2

Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA

Multifunctional Pyrazolo[3,4-d]Pyrimidine Analogs (HCQ-PPs): Design, Synthesis and Anti-SARS-CoV-2 Evaluation

Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors

Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CLpro enzyme for COVID-19 therapy: a computer-aided drug design approach

Design, Synthesis of Novel Pyrido[2,3-d] pyrimidine Derivatives as SARS-CoV-2 Mpro Inhibitors for COVID-19 Therapy

Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors

In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2